Ladenburg Thalmann Financial Services’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-25
| Closed | – | – | 5187 |
|
|
2018
Q2 | $0 | Hold |
25
| – | – | ﹤0.01% | 5110 |
|
|
2018
Q1 | $0 | Hold |
25
| – | – | ﹤0.01% | 5126 |
|
|
2017
Q4 | $0 | Hold |
25
| – | – | ﹤0.01% | 5050 |
|
|
2017
Q3 | $0 | Hold |
25
| – | – | ﹤0.01% | 4948 |
|
|
2017
Q2 | $1K | Hold |
25
| – | – | ﹤0.01% | 4718 |
|
|
2017
Q1 | $1K | Hold |
25
| – | – | ﹤0.01% | 4697 |
|
|
2016
Q4 | $1K | Hold |
25
| – | – | ﹤0.01% | 4646 |
|
|
2016
Q3 | $2K | Hold |
25
| – | – | ﹤0.01% | 4467 |
|
|
2016
Q2 | $2K | Hold |
25
| – | – | ﹤0.01% | 4392 |
|
|
2016
Q1 | $2K | Hold |
25
| – | – | ﹤0.01% | 4377 |
|
|
2015
Q4 | $4K | Hold |
25
| – | – | ﹤0.01% | 4125 |
|
|
2015
Q3 | $5K | Hold |
25
| – | – | ﹤0.01% | 3920 |
|
|
2015
Q2 | $7K | Hold |
25
| – | – | ﹤0.01% | 3878 |
|
|
2015
Q1 | $6K | Buy |
+25
| New | +$6K | ﹤0.01% | 3885 |
|